Replimune Group
REPL
157 hedge funds and large institutions have $943M invested in Replimune Group in 2024 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 66 increasing their positions, 32 reducing their positions, and 20 closing their positions.
106% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 32
70% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 20
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
23% more capital invested
Capital invested by funds: $767M → $943M (+$177M)
9% more funds holding
Funds holding: 144 → 157 (+13)
2% more call options, than puts
Call options by funds: $536K | Put options by funds: $528K
0.99% more ownership
Funds ownership: 102.38% → 103.37% (+0.99%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$37.7M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$18.2M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$13.2M |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$11.5M |
| 5 |
RI
RTW Investments
New York
|
+$11.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
B
Braidwell
Stamford,
Connecticut
|
-$19.4M |
| 2 |
FIS
FCPM III Services
Naarden,
Netherlands
|
-$10.9M |
| 3 |
Morgan Stanley
New York
|
-$7.8M |
| 4 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$5.91M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$4.97M |
REPL Hedge Fund Activity: Q4 2024 in Review
157 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q4 2024, worth a combined $943M — up 23% from $767M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new REPL positions and 20 closed out — a net gain of 14 holders — while 66 added to existing stakes and 32 trimmed.
The largest buyer was Sofinnova Investments, adding an estimated $37.7M. The largest seller was Braidwell, cutting an estimated $19.4M.
- 157 institutional investors held Replimune Group (REPL) as of Q4 2024, up from 144 in Q3 2024.
- Funds reported $943M of Replimune Group stock for Q4 2024, up 23% quarter-over-quarter.
- 34 funds opened new Replimune Group positions in Q4 2024 and 20 closed out, a net change of +14 holders.
- The largest Replimune Group buyer in Q4 2024 was Sofinnova Investments, an estimated $37.7M added.
- The largest Replimune Group seller in Q4 2024 was Braidwell, an estimated $19.4M sold.
Based on aggregated 13F filings for Q4 2024.